NSAIDS/DMARDS/GOUT Flashcards

(53 cards)

1
Q

MOA PARACETAMOL

A

Selectively inhibits COX-3. Weak COX-1 and COX-2
inhibitor. Inhibits prostaglandin synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Preferred antipyretic in children

A

Paracetamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of Paracetamol Overdose

A

Oxidation to a cytotoxic intermediate called N-acetyl-p-benzoquinoneimine
(NAPQI) by phase I CYP450 enzymes (CYP2E1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antidote of Paracetamol toxicity?

A

antidote is N-acetylcysteine (NAC), a sulfhydryl donor necessary
for detoxification of paracetamol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Development of Paracetamol Overdose 24-48 hrs, what manifestation?

A

Hepatic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Development of Paracetamol Overdose 3-5 days, what manifestation?

A

Extremely high liver enzymes (>10,000 IU/L)

Maximal abnormalities and hepatic failure
Jaundice, hepatic encephalopathy, renal failure,
myocardial injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOA ASPIRIN (Acetylsalicylic acid, ASA), Salsalate,
Sodium salicylate, Choline salicylate, Magnesium salicylate

A

Nonselective, IRREVERSIBLE COX 1&2 inhibitor.
Reduces platelet production of thromboxane A2, a
potent stimulator of platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Associated with Reye’s syndrome in children

Prevents uric acid excretion (don’t use in gout)

A

SALICYLATES

ASPIRIN (Acetylsalicylic acid, ASA), Salsalate,
Sodium salicylate, Choline salicylate, Magnesium salicylate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dose range of aspirin
* low range (<300 mg/d)

for?

A

o effective in reducing platelet aggregation
o follows first-order elimination kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dose range of aspirin
* intermediate doses (300–2400 mg/d)

for?

A

o antipyretic and analgesic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dose range of aspirin

  • high doses (2400–4000 mg/d)
    for?
A

o anti-inflammatory effects
o follows zero-order elimination kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA?

IBUPROFEN, Diclofenac, Diflunisal, Etodolac, Fenoprofen,
Flurbiprofen, KETOPROFEN, Nabumetone, Naproxen,
Oxaprozin, PIROXICAM, Sulindac, Tolmetin, MEFENAMIC ACID,
Bromfenac, Meclofenamate, Suprofen, Aceclofenac

A

NON SELECTIVE NSAIDS

  • Reversible COX 1 and 2 Inhibition.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

prevents NSAIDinduced
gastritis

A

MISOPROSTOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NSAIDs (in general) may cause premature closure of

A

DUCTUS ARTERIOSUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

used to close PDA

A

Ibuprofen and Indomethacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Post-surgical analgesic control (moderate to severe,
short-term), mainly used for analgesia not for antiinflammatory
effect

A

Ketorolac, Dexketoprofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA?

CELECOXIB, Etoricoxib,
Rofecoxib, Valdecoxib, Parecoxib [X],

A

Selective COX-2 inhibitor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which cox2 selective inhibitors are withdrawn from the
market due to increased incidence of thrombosis

A

Rofecoxib and Valdecoxib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Parecoxib is pregnancy category

A

Category X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MOA: Inhibits AICAR (5-Aminoimidazole-4-Carboxamide
Ribonucleotide) transformylase and thymidylate
synthetase, with secondary effects on
polymorphonuclear chemotaxis

A

METHOTREXATE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

DMARD of first choice to treat rheumatoid arthritis

A

Methotrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MOA? Forms phosphoramide mustard, which cross-links
DNA to prevent cell replication. Suppresses T-cell and Bcell
function

A

Cyclophosphamide [D]

23
Q

RESCUE AGENT FOR CYCLOPHOSPHAMIDE?

24
Q

MOA: Forms 6-Thioguanine, suppressing inosinic acid
synthesis, B-cell and T-cell function, immunoglobulin
production, and interleukin-2 secretion

25
MOA: Suppression of T-lymphocyte responses to mitogens, decreased leukocyte chemotaxis, Stabilization of lysosomal enzymes, Inhibition of DNA and RNA synthesis, Trapping of free radicals
CINCHONA ALKALOIDS: CHLOROQUINE, HYDROXYCHLOROQUINE
26
Cinchonism: Headache Tinnitus, Vertigo , irreversible retinal damage, Dyspepsia, Nausea, Vomiting, Abdominal pain, Rashes, Nightmares side effects of?
CINCHONA ALKALOIDS: CHLOROQUINE, HYDROXYCHLOROQUINE
27
MOA? Mabs: bind and neutralize TNF-a Etanercept: a ‘decoy receptor’ that forms a complex with TNF-a and promotes its phagocytosis
INFLIXIMAB, ADALIMUMAB, ETANERCEPT, CERTOLIZUMAB, GOLIMUMAB
28
MOA: Binds to cyclophilin to act as a calcineurin inhibitor. Inhibits interleukin-1 and interleukin-2 receptor transcription thereby blocking T-cell activation
Cyclosporine
29
Most important and limiting side effect of Cyclophosphorine?
Nephrotoxicity (most important and limiting SE) Gingival hyperplasia and hirsutism
30
MOA: Active product (mycophenolic acid) inhibits inosine monophosphate dehydrogenase (important enzyme in the guanine nucleotide synthesis) and inhibits T-cell lymphocyte proliferation
Mycophenolate Mofetil
31
Least Toxic for SLE nephritis
Mycophenolate Mofetil [D]
32
Associated with invasive CMV infection
Mycophenolate Mofetil [D]
33
MOA: * Inhibits the activation of T Cells by binding to CD80 and CD86 on the APC * CTLA-4-IgFc fusion protein
ABATACEPT
34
MOA: Its active metabolite inhibits Dihydroorotate dehydrogenase → decreased synthesis of ribonucleotide and arrest of stimulated cells in the G1 phase of cell growth. Inhibits T cell proliferation and production of autoantibodies by B cells.
LEFLUNOMIDE [X]
35
MOA: Binds to CD20 antigen on the surface of B lymphocytes → reduced inflammation by decreasing the presentation of antigens to T lymphocytes and inhibits secretion of cytokines
RITUXIMAB
36
MOA : Binds to IL-6 → decreased T cell activation and inflammatory process
Tocilizumab (To6lizumab)
37
A monoclonal antibody against IL-17; used for psoriasis and ankylosing spondylitis
SECUKINUMAB
38
A monoclonal antibody against IL-2; used to prevent rejection during organ transplantation
BASILIXIMAB
39
A monoclonal antibody against IL-12 and IL- 23; used for Crohn’s disease and psoriasis (Paskuhan sa UST on 12/23)
USTEKINUMAB
40
The management of gout has 3 strategies:
1. reducing inflammation during acute attacks 2. accelerating renal excretion of uric acid with uricosuric drugs 3. reducing the conversion of purines to uric acid by xanthine oxidase
41
is commonly used in the initial treatment of gout as the replacement for colchicine
INDOMETHACIN
42
Aspirin is not used in GOUT due to
Aspirin is not used due to its renal retention of uric acid at low doses
43
MOA Inhibits microtubule assembly and LTB4 production leading to decreased macrophage migration and phagocytosis
COLCHICINE
44
adverse effect which signals toxicity from colchicine * Not to be given to patients with eGFR of <30
DIARRHEA
45
MOA: A urate oxidase that catalyzes oxidation of uric acid into allantoin (more soluble and inactive metabolite)
PEGLOTICASE, RASBURICASE
46
MOA: Compete with uric acid for reabsorption in the proximal tubules via the URAT1 transporter. Increase uric acid excretion.
PROBENECID, Lesinurad
47
A required minimum 30 ml/min GFR is important before starting what drug?
Probenecid
48
MOA: Active metabolite (alloxanthine) that irreversibly inhibits Xanthine Oxidase and lowers production of uric acid
ALLOPURINOL
49
MOA: Nonpurine reversible that is an inhibitor of xanthine oxidase (more selective than allopurinol). Lowers production of uric acid.
FEBUXOSTAT
50
1st line treatment for chronic gout, Tumor lysis syndrome
ALLOPURINOL
51
USED FOR Chronic gout, Tumor lysis syndrome, Allopurinol intolerance
FEBUXOSTAT
52
Inhibits metabolism of mercaptopurine and azathioprine * Withheld for 1–2 weeks after an acute episode of gouty arthritis
ALLOPURINOL (coadministered with colchicine or indomethacin to avoid an acute attack)
53
Withheld for 1–2 weeks after an acute episode of gouty arthritis
FEBUXOSTAT (coadministered with colchicine or indomethacin to avoid an acute attack) * Febuxostat is more effective than Allopurinol